U.S. net product revenue in first full year Intranasal epinephrine platform advances with Phase 2b CSU data expected mid-2026 Strong balance sheet of $245.0 million in ...
Shares of certain biotech firms were rising ahead of market open on Monday on news of the departure of the FDA’s vaccine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results